MiNK Therapeutics, Inc. Gain (Loss) on Disposition of Assets
MiNK Therapeutics, Inc. (INKT) reported Gain (Loss) on Disposition of Assets of -$169.80 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-31.
Financial Statements › Income Statement › Other Income
us-gaap:GainLossOnDispositionOfAssets1 · last filed 2026-08-13
- MiNK Therapeutics, Inc. gain (loss) on disposition of assets for fiscal 2025 was -$169.80K.
| Period end | Gain (Loss) on Disposition of Assets 6 month | Gain (Loss) on Disposition of Assets 12 month |
|---|---|---|
| 2025-12-31 | -$169.80K 10-K · filed 2026-03-31 | |
| 2025-06-30 | -$167.10K 10-Q · filed 2026-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |